- Home
- About Us
- Divisions
- Adolescent and Young Adult Medicine
- Allergy and Immunology
- Blood and Marrow Transplantation and Cellular Therapies
- Cardiology
- Child Advocacy
- Emergency Medicine
- Endocrinology
- Gastroenterology, Hepatology and Nutrition
- General Academic Pediatrics
- Genetic and Genomic Medicine
- Health Informatics
- Hematology-Oncology
- Infectious Diseases
- Nephrology
- Neurology and Child Development
- Newborn Medicine
- Paul C. Gaffney Division of Pediatric Hospital Medicine
- Pulmonology
- Rheumatology
- Centers & Institutes
- Center for Pediatric Research in Obesity and Metabolism
- Center for Rare Disease Therapy
- Children's Neuroscience Institute
- Cystic Fibrosis Research Center
- Institute for Infection, Inflammation, and Immunity in Children
- Pediatric Asthma Center
- Pediatric Institute for Heart Regeneration and Therapeutics
- Richard King Mellon Foundation Institute for Pediatric Research
- Pittsburgh Vaccine Trials Unit
- The Pittsburgh Study
- Research
- Diversity
- Education
- Faculty Affairs
- News
- People
- Podcasts
Translational Research
Our work in translational research seeks to utilize our understanding of rare disease processes to develop interventions to improve patient lives. These interventions can include gene therapy to attempt to correct the underlying genetic problem or lifestyle changes, such as diet control, that can minimize the impact of a particular disease on daily living.
Lysosomal Storage Disorders
A group of approximately 60 conditions that have unique causes, characteristics, treatment approaches, and research opportunities.
Amish and Plain Communities
Pitt's proximity to Amish, Mennonite, and Plain communities in western and northern Pennsylvania, New York, and eastern Ohio allows us to research certain genetic disorders which disproportionately affect these populations.
Fatty Acid Oxidation Disorders
Mitochondrial fatty acid oxidation (FAO) is a pathway of energy generation and is active during times of fasting or physiologic stress.
Congenital Disorders of Glycosylation
A disorder in which the body’s ability to modify proteins is disrupted, leading to clinical disease.
Inborn Errors of Metabolism
Rare genetic (inherited) disorders where the body cannot properly convert food into energy
Branched Chain Amino Acid Metabolism
Organic acidemias, such as methylmalonic acidemia (MMA) and propionic acidemia (PA), are inherited disorders that interfere with the body’s ability to properly use certain enzymes to process carbohydrates, amino acids, and fatty acid oxidation.
Mitochondrial Diseases and NAMDC
Mitochondrial diseases comprise a group of relatively rare but very serious genetic disorders.
Pyruvate Dehydrogenase Complex
A type of metabolic disease when individuals are not able to break down nutrients in food to use for energy.
Precision Medicine
Congenital abnormalities and genetic disorders are a leading cause of infant mortality in the United States.
Phenylketonuria
PKU (phenylketonuria) is a genetic disorder that impairs the body’s ability to break down phenylalanine (Phe).
Hypophosphatasia (HPP)
Hypophosphatasia (HPP) is an ultra-rare bone disorder caused by genetic changes in the ALPL gene.